MS/EAE Microglia Th1/Th17 A1 astrocyte ACDT Neuroinflammation Blood-brain barrier a b s t r a c t Multiple sclerosis (MS) is an autoimmune disorder characterized by the central nervous system (CNS) infiltration of myelin-specific pathogenic T cells followed by brain inflammation in association with demyelination. Similarly, experimental autoimmune encephalomyelitis (EAE), the animal model of MS, also exhibits increased CNS infiltration of pathogenic T cells, including Th1 and Th17, leading to detrimental effects of neuroinflammation and demyelination. We previously reported that 3H-1,2-dithiole-3-thione (D3T), the structurally-simplest of the sulfur-containing dithiolethiones, exerted a promising therapeutic effect in EAE. In the current study we report that 5-Amino-3-thioxo-3H-(1,2)dithiole-4-carboxylic acid ethyl ester (ACDT), a substituted derivative of D3T, exhibits anti-inflammatory properties in EAE. ACDT, administered post immunization, delayed disease onset and reduced disease severity in chronic C57BL/6 EAE, and ACDT, administered during disease remission, suppressed disease relapse in relapsing-remitting SJL/J EAE. Further analysis of the cellular and molecular mechanisms underlying the protective effects of ACDT in EAE revealed that ACDT inhibited pathogenic T cell infiltration, suppressed microglia activation, repressed neurotoxic A1 astrocyte generation, lessened blood-brain barrier disruption, and diminished MMP3/9 production in the CNS of EAE. In summary, we demonstrate that ACDT suppresses neuroinflammation and ameliorates disease severity in EAE through multiple cellular mechanisms. Our findings suggest the potential of developing ACDT as a novel therapeutic agent for the treatment of MS/EAE.
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Introduction
Multiple sclerosis (MS) is an autoimmune disorder characterized by the CNS infiltration of myelin-specific pathogenic T cells and subsequent brain inflammation in association with myelin sheath deterioration (Fletcher et al., 2010; Kurschus, 2015; Yadav et al., 2015) . Experimental autoimmune encephalomyelitis (EAE) is a commonly used animal model to study MS. Several T cell subsets, including CD4 + T cell lineages of Th1 and Th17, CD8 + T cells, and IL-17-producting cdT cells, are essential for the pathogenesis of EAE (Camara et al., 2013; Codarri et al., 2011; Grifka-Walk et al., 2015; Jager et al., 2009; McWilliams et al., 2015) . In addition, antigen presenting cells such as peripheral dendritic cells and CNS microglial cells have been shown to play a pivotal role in the promotion of differentiation and reactivation of pathogenic T cells, respectively (Croxford et al., 2015) . In our previous study, we demonstrated the amelioration of EAE by the agent 3H-1,2-dithiole-3-thione (D3T) (Kuo et al., 2016) . The promising in vivo activity of D3T, the structurally-simplest of the sulfur-containing dithiolethiones, is a composite of its physicochemical, pharmacokinetic, and pharmacodynamic properties. Further improvement in the activity of D3T can be made by optimizing these properties through structural modifications. As such, we aimed to determine the influence of modifications of D3T structure on EAE activity. We sought a molecule that retains the dithiolethione pharmacophore, but has functional groups that are easily modified. Our search identified compound 5-Amino-3-thioxo-3H-(1,2)dithiole-4-carboxylic acid ethyl ester (ACDT), a dithiolethione with ethyl ester and primary amine functional groups (Supplemen-
